Impact of postmenopausal hormone therapy on cardiovascular events and cancer. Combining thromboembolic events with cardiovascular events does not support odds ratio of 0.7.
Sundkvist
T
T
D002318:Cardiovascular Diseases / Q000517:prevention & control*; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D005260:Female; D006801:Humans; D015201:Meta-Analysis as Topic; D016017:Odds Ratio; D013923:Thromboembolism / Q000139:chemically induced